Dana-Farber Cancer Institute, The Broad Institute and Bayer patent PDE3A and PDA3B inhibitors Feb. 25, 2019
Novel double-hit pre-eclampsia mouse model mimics human clinical course of the condition Feb. 25, 2019
Rizmoic approved by EC for the treatment of OIC in adults previously treated with a laxative Feb. 25, 2019
Lusutrombopag approved in Europe for the treatment of severe thrombocytopenia in adults with CLD Feb. 25, 2019
Euglycemic ketoacidosis in SGLT2 inhibitor-treated rats requires dehydration and insulinopenia Feb. 25, 2019
RSS